• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOPHYSA POLARIS; POLARIS ADJUSTABLE VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOPHYSA POLARIS; POLARIS ADJUSTABLE VALVE Back to Search Results
Model Number SPVA-2010
Device Problems Device Difficult to Program or Calibrate (1496); Device Operates Differently Than Expected (2913); Reset Problem (3019)
Patient Problem Hydrocephalus (3272)
Event Date 06/01/2016
Event Type  malfunction  
Manufacturer Narrative
Waiting for the device to be returned for investigation.
 
Event Description
Patient with hydrocephalus by obstructions in foramen of luschka was implanted with a polaris valve in (b)(6) 2014.The patient remained well until (b)(6) 2015 when the typical symptoms of hydrocephalus was observed, the ct showed re-occurence of hydrocephalus.The valve not remained the setted pressure and the valve was replaced in (b)(6) 2015 with a new polaris valve with the initial setting of 110mm h2o.In (b)(6) 2016, the patient presented headache and disequilibrium and the doctor found the valve pressure was set to 30mm h2o.The doctor changed the setting back to 110mm h2o and the patient returned in follow up visit (2days -1week later) showing a reset to 50mm h2o.The valve was reset to 150mm h2o and was again found to auto change to 50mm h2o during follow-up visit.This happened 4 times and the patient was admitted to hospital to ensure being away from any external magnetic medium that could change the setting.The valve was set by the doctor to 110mm h2o and the next day, the pressure setting was shown to be back to 70mm h2o/ and the patient showed symptoms of overdrainage (collapse of ventricles) and the patient is prescribed to explant the valve and to be replaced by a new drainage system.
 
Event Description
Patient with hydrocephalus by obstructions in foramen of luschka was implanted with a polaris valve in (b)(6) 2014.The patient remained well until (b)(6) 2015 when the typical symptoms of hydrocephalus was observed, the ct showed re-occurrence of hydrocephalus.The valve not remained the setted pressure and the valve was replaced in (b)(6) 2015 with a new polaris valve with the initial setting of 110mmh2o.In (b)(6) 2016, the patient presented headache and disequilibrium and the doctor found the valve pressure was set to 30mmh2o.The doctor changed the setting back to 110mm h2o and the patient returned in follow up visit (2 days -1week later) showing a reset to 50mmh2o.The valve was reset to 150mmh2o and was again found to auto change to 50mmh2o during follow-up visit.This happened 4 times and the patient was admitted to hospital to ensure being away from any external magnetic medium that could change the setting.The valve was set by the doctor to 110mmh2o and the next day, the pressure setting was shown to be back to 70mmh2o/ and the patient showed symptoms of overdrainage (collapse of ventricles) and the patient is prescribed to explant the valve and to be replaced by a new drainage system.
 
Manufacturer Narrative
The testing performed in our laboratory showed adjustments difficulties, but nothing, in the visual or functional controls performed on the valve, could explain this situation.We could not recreate the issue encountered by the user as we did not observe any deprogramming of the valve.In addition, no x-ray image was sent to confirm the adjustment of the valve and there is no certainty that the compass designed for the reading and adjustment of polaris valves was used to verify the setting values.The difficulties observed with the adjustment of the rotor might explain the situation faced by the user.The laboratory testing performed indeed revealed some difficulties to adjust the pressure.Therefore, in the absence of x-ray image, we cannot be certain that the valve pressure was actually well-adjusted in the first place.It is very likely that the pressure remained on its initial setting all along and that the issue encountered by the user was not a case of deprogramming, but of adjustment difficulties.The latter is well-known in the lifecycle of such products.The instruction for use delivered with each valve provides many details regarding the potential cases of adjustment difficulties and the suggested measures to prevent it.
 
Event Description
Patient with hydrocephalus by obstructions in foramen of luschka was implanted with a polaris valve in (b)(6) 2014.The patient remained well until (b)(6) 2015 when the typical symptoms of hydrocephalus was observed, the ct showed re-occurrence of hydrocephalus.The valve not remained the settled pressure and the valve was replaced in (b)(6) 2015 with a new polaris valve with the initial setting of 110mmh2o.In (b)(6) 2016, the patient presented headache and disequilibrium and the doctor found the valve pressure was set to 30mmh2o.The doctor changed the setting back to 110mm h2o and the patient returned in follow up visit (2days -1week later) showing a reset to 50mmh2o.The valve was reset to 150mmh2o and was again found to auto change to 50mmh2o during follow-up visit.This happened 4 times and the patient was admitted to hospital to ensure being away from any external magnetic medium that could change the setting.The valve was set by the doctor to 110mmh2o and the next day, the pressure setting was shown to be back to 70mmh2o/ and the patient showed symptoms of overdrainage (collapse of ventricles) and the patient is prescribed to explant the valve and to be replaced by a new drainage system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLARIS
Type of Device
POLARIS ADJUSTABLE VALVE
Manufacturer (Section D)
SOPHYSA
5 rue guy moquet
orsay, 91400
FR  91400
Manufacturer (Section G)
SOPHYSA
5 rue guy moquet
orsay, 91400
FR   91400
Manufacturer Contact
jean-christophe audras
5 rue guy moquet
orsay, 91400
FR   91400
3169353500
MDR Report Key5771541
MDR Text Key49766823
Report Number3001587388-2016-16251
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K031097
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 12/12/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/01/2019
Device Model NumberSPVA-2010
Device Catalogue NumberSPVA-2010
Device Lot NumberB0460
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/06/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received06/20/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-